Lanean...
Virologic response and haematologic toxicity of boceprevir- and telaprevir-containing regimens in actual clinical settings
Effectiveness, safety and tolerability of boceprevir (BOC) and telaprevir (TPV) in actual clinical settings remain unknown. We determined rates of sustained virologic response (SVR) and haematologic adverse effects among persons treated with BOC- or TPV-containing regimens, compared with pegylated i...
Gorde:
| Argitaratua izan da: | J Viral Hepat |
|---|---|
| Egile Nagusiak: | , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2014
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5020421/ https://ncbi.nlm.nih.gov/pubmed/25524834 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jvh.12375 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|